Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
The study team will take two or three tubes of blood on three occasions during the course of
chemotherapy. The total amount of blood required for this research project is 64mL
(approximately 4 tablespoons).
This will allow better understanding of the changes that take place in the blood and the HIV
virus itself. It is hoped that this will provide new insights that may aid the understanding
and treatment of HIV patients with lymphoma.
Observational Model: Case Control
Development of multi-drug resistance (in terms of expression of transmembrane transporters and their transcriptional regulators) in HIV-infected patients with lymphoma.
Marta Boffito, Dr
St Stephen's AIDS Trust
United Kingdom: Medicines and Healthcare Products Regulatory Agency